Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

An equine herpesvirus type 1 (EHV-1) expressing VP2 and VP5 of serotype 8 bluetongue virus (BTV-8) induces protection in a murine infection model.

Ma G, Eschbaumer M, Said A, Hoffmann B, Beer M, Osterrieder N.

PLoS One. 2012;7(4):e34425. doi: 10.1371/journal.pone.0034425. Epub 2012 Apr 12.

2.

Herpesvirus BACs: past, present, and future.

Warden C, Tang Q, Zhu H.

J Biomed Biotechnol. 2011;2011:124595. doi: 10.1155/2011/124595. Epub 2010 Oct 27. Review.

3.

Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Ramasamy S, Liu CQ, Tran H, Gubala A, Gauci P, McAllister J, Vo T.

Br J Pharmacol. 2010 Oct;161(4):721-48. doi: 10.1111/j.1476-5381.2010.00939.x. Review.

4.

Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus.

Martin SS, Bakken RR, Lind CM, Garcia P, Jenkins E, Glass PJ, Parker MD, Hart MK, Fine DL.

Vaccine. 2010 Apr 19;28(18):3143-51. doi: 10.1016/j.vaccine.2010.02.056. Epub 2010 Mar 1.

Supplemental Content

Support Center